Cell lineage characteristics of human prostatic stromal cells cultured in vitro

Prostate

Volumn 43, Issue 1, 2000, Pages 20-30

  Janßen, Michael ^a   Albrecht, Martin ^a   Möschler, Oliver ^a   Renneberg, Heiner ^a   Fritz, Barbara ^a   Aumüller, Gerhard ^a   Konrad, Lutz ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Gene expression; Immunohistochemistry; In vitro cell culture; Prostate; Stroma

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL STRUCTURE; CELL VIABILITY; CLASSIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARDIZATION; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY;

CELL DIVISION; CELL LINE; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HORMONES; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; MIDDLE AGED; MUSCLE, SMOOTH; PROSTATE; RECEPTORS, ANDROGEN; STROMAL CELLS;

EID: 0343238963     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(20000401)43:1<20::AID-PROS4>3.0.CO;2-6     Document Type: Article

References (56)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132: 474-479.
2. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978;16:409-420.
3. Bartsch G, Muller HR, Oberholzer M, Rohr HP. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979;122:487-491.
4. Shapiro E, Hartanto V, Perlman EJ, Tang R, Wang B, Lepor H. Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal process. Prostate 1997;33:177-182.
5. McNeal JE. Prostate. In: Sternberg SS, editor. Histology for pathologists. New York: Raven Press; 1992. p 749-763.
6. Wu YX, Kawabe K. Primary culture of smooth muscle cells from benign prostatic hyperplasia. J Smooth Muscle Res 1994;30:51-56.
7. Kooistra A, Elissen NMJ, König JJ, Vermey M, van der Kwast T, Romijn JC, Schröder FH. Immunocytochemical characterization of explant cultures of human prostatic stromal cells. Prostate 1995;27:42-49.
8. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, Lee C. Stromal cells of the human prostate: initial isolation and characterization. Prostate 1996;28:89-97.
9. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H. Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30:117-129.
10. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA. The LNCaP cell line - a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 1980;37:115-132.
11. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17:16-23.
12. Stone KR, Mickey DH, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978;21:274-281.
13. Oishi K, Romijn JC, Schröder FH. Cell separation and characterization of epithelial cells from human benign prostatic hyperplasia. Prostate 1981;2:281-289.
14. Peehl DM, Stamey TA. Growth responses of normal, benign hyperplasia, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone. Prostate 1986;8:51-61.
15. Chaproniere DM, McKeehan WL. Serial culture of single adult human prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res 1986;46:819-824.
16. Merchant DJ. Terminally differentiating epithelial tissue in primary explant culture: a model of growth and development. In Vitro Cell Dev Biol 1990;26:543-553.
17. Merchant DJ. Primary explant culture of human prostate tissue: a model for the study of prostate physiology and pathology. Prostate 1990;16:103-126.
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
19. Romijn JC, Verkoelen CF, Schroeder FH. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. Prostate 1988;12:99-110.
20. Schulz J, Dettlaff S, Fritzsche U, Harms U, Schiebel H, Derer W, Fusenig NE, Hülsen A, Böhm M. The amido black assay: a simple and quantitative multipurpose test of adhesion, proliferation, and cytotoxicity in microplate cultures of keratinocytes (HaCaT) and other cell types growing adherently or in suspension. J Immunol Methods 1994;167:1-13.
21. Aumüller G, Seitz J, Bischof W. Immunohistochemical study on the initiation of acid phosphatase secretion in the human prostate. J Androl 1983;4:183-191.
22. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:752-755.
23. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987;47:5616-5619.
24. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 1988;2:1265-1275.
25. Dunnett CW. New tables for multiple comparison with a control. Biometrics 1964;20:482-491.
26. Renneberg H, Friedetzky A, Konrad L, Kurek R, Weingärtner K, Wennemuth G, Tunn UW, Aumüller G. Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread. Urol Res 1999;27:23-27.
27. Shapiro E, Hartanto V, Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 1992;147:1167-1170.
28. Collins AT, Zhiming B, Gilmore K, Neal DE. Androgen and oestrogen responsiveness of stromal cells derived from the human hyperplastic prostate: oestrogen regulation of the androgen receptor. J Endocrinol 1994;143:269-277.
29. Peehl DM, Sellers RG. Basic FGF, EGF, and PDGF modify TGFβ-induction of smooth muscle cell phenotype in human prostatic stromal cells. Prostate 1998;35:125-134.
30. Sherwood ER, Berg LA, McEwan RN, Pasciak RM, Kozlowski JM, Lee C. Two-dimensional profiles of cultured stromal and epithelial cells from hyperplastic human prostate. J Cell Biochem 1989;40:201-214.
31. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC. Association of transforming growth factor-β1 with prostate cancer: an immunohistochemical study. Hum Pathol 1993;24:4-9.
32. Yazawa H, Saita Y, Iida E, Honma Y, Morita T, Honda K. Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 1994;152:2173-2177.
33. Cussenot O, Berthon P, Cochand-Priollet B, Maitland NJ, LeDuc A. Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp Cell Res 1994;214:83-92.
34. Sensibar JA, Pruden SJ, Kasjanski RZ, Rademaker A, Lee C, Grayhack JT, Kozlowski JM. Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate 1998;38:110-117.
35. Esterre P, Melin M, Serrar M, Grimaud JA. New specific markers of human and mouse fibroblasts. Cell Mol Biol 1992;38:297-301.
36. Janin A, Konttinen YT, Gronblad M, Karhunen P, Gosset D, Malmstrom M. Fibroblast markers in labial salivary gland biopsies in progressive systemic sclerosis. Clin Exp Rheumatol 1990; 8:237-242.
37. Saalbach A, Anderegg U, Bruns M, Schnabel E, Herrmann K, Haustein UF. Novel fibroblast-specific monoclonal antibodies: properties and specificities. J Invest Dermatol 1996;106:1314-1319.
38. Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffitt J, Wilber K, Lieber MM, Liu W, Smith DI. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 1998;58:759-766.
39. Mitelman F, Mertens F, Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 1997;15:417-474.
40. Roghani M, Moscatelli D. Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanims. J Biol Chem 1992;267:22156-22162.
41. Story MT, Livingston B, Baeten L, Swartz SJ, Jacobs SC, Begun FP, Lawson RK. Cultured human prostate-derived fibroblasts produce a factor that stimulates their growth with properties indistinguishable from basic fibroblast growth factor. Prostate 1989;15:355-365.
42. Story MT, Hopp KA, Meier DA, Begun FP, Lawson RK. Influence of transforming growth factor β1 and other growth factors on basic fibroblast growth factor level and proliferation of cultured human prostate-derived fibroblasts. Prostate 1993;22:183-197.
43. Story MT, Hopp KA, Molter M, Meier DA. Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors 1994; 10:269-280.
44. Sherwood ER, Fong C-J, Lee C, Kozlowski JM. Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology 1992;130:2955-2963.
45. Peehl DM, Stamey TA, Rubin JS. Fibroblast growth factors can replace epidermal growth factor for clonal proliferation of human prostate epithelial cells. J Urol 1991;145:331.
46. Story MT, Hopp KA, Meier DA. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate 1996;28:219-226.
47. Sadi MV, Barrack ER. Androgen receptors and growth fraction in metastatic prostate cancer as predictors of time to tumour progression after hormonal therapy. Cancer Surv 1991;11:195-215.
48. Mohler JL, Chen Y, Hamil K, Hall SH, Cidlowski JA, Wilson EM, French FS, Sar M. Androgen and glucocorticoid receptors in the stroma and epithelium of prostatic hyperplasia and carcinoma. Clin Cancer Res 1996;2:889-895.
49. Hayward SW, Rosen MA, Cunha GR. Stromal-epithelial interactions in the normal and neoplastic prostate. Br J Urol [Suppl] 1997;79:18-26.
50. Levine AC, Ren M, Huber GK, Kirschenbaum A. The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 1992;130:2413-2419.
51. Krieg M, Bartsch W, Thomsen M, Voigt KD. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate. J Steroid Biochem 1983;19:155-161.
52. Seitz G, Wernert N. Immunohistochemical estrogen receptor demonstration in the prostate and prostate cancer. Pathol Res Pract 1987;182:792-796.
53. Wernert N, Gerdes J, Loy V, Seitz G, Scherr O, Dhom G. Investigations of the estrogen (ER-ICA-test) and the progesterone receptor in the prostate and prostatic carcinoma on immunohistochemical basis. Virchows Arch [A] 1988;412:387-391.
54. Kirschenbaum A, Ren M, Erenburg I, Schachter B, Levine AC. Estrogen receptor messenger RNA expression in human benign prostatic hyperplasia: detection, localization, and modulation with a long-acting gonadotropin-releasing hormone antagonist. J Androl 1994;15:528-533.
55. Feneley MR, Puddefoot JR, Xia S, Sowter C, Slavin G, Kirby RS, Vinson GP. Zonal biochemical and morphological characteristics in BPH. Br J Urol 1995;75:608-613.
56. Srinivasan G, Campbell E, Bashirelahi N. Androgen, estrogen, and progesterone receptors in normal and aging prostates. Microsc Res Tech 1995;30:293-304.